Penanganan Demam Reumatik Pada Anak

• Main Author: Perpustakaan UGM, i-lib
• Format: Article NonPeerReviewed
• Published: [Yogyakarta] : Universitas Gadjah Mada 1989
• Subjects: Jurnal i-lib UGM
• Online Access: https://repository.ugm.ac.id/18823/; http://i-lib.ugm.ac.id/jurnal/download.php?dataId=1631
• Institution: Universitas Gadjah Mada

ABSTRAK Rheumatic fever is an inflammatory syndrome which some times follows beta haemolytic group A Streptococcal infections of the throat, and characteristically tends to recur. The incidence of rheumatic fever has fallen sharply in economically developed countries, although among the majority of the world's population, rheumatic heart disease remains the most common cardiovascular cause of death. The recent resurgence of rheumatic fever in middle-class families in some part of the economically developed world has re-emphasized the fact that higher standard of living and avaibility of primary health care, are not the complete answer to the decrease in rheumatic fever. The association between group A beta haemolytic streptococcal upper respiratory tract infection and the subsequent development of acute rheumatic fever is well established. Rheumatic fever may affect a number of organs and tissues, singly or in combination of them, therefore the diagnosis is based on appropriate combination of them. The appropriate combination has been formulated in Jones criteria. Management of the diseases should be started with bed rest for 2 to 6 weeks, depending on the nature and severity of the attack. All patiens should be given antibiotic. Anti inflamatory treatment is given only to patients with arthritis and/or carditis. Secondary prophylaxis should be performed in preventing the subsequent development of recurrent attacks of rheumatic fever. Immunoprophylaxis due to the discovery of epitopes or immimodeterminant parts of M-protein molecule looks very promising. It is concluded that until now rheumatic fever is still a major health problem especially in many developing countries. The development of management and prophylaxis measures is still needed. Key Words : rheumatic fever, rheumatic heart disease, penicillin prophylaxis, imnumoprophylaris, carditis.